Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shilpa Medicare Limited ( (IN:SHILPAMED) ) has issued an update.
Shilpa Medicare Limited has released the transcript of its Q1 FY26 earnings conference call, which took place on August 13, 2025. This release provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
More about Shilpa Medicare Limited
Shilpa Medicare Limited operates in the pharmaceutical industry, focusing on the development and production of affordable healthcare solutions. The company is known for its innovative approach to creating cost-effective pharmaceutical products.
Average Trading Volume: 13,147
Technical Sentiment Signal: Buy
Current Market Cap: 88.64B INR
See more insights into SHILPAMED stock on TipRanks’ Stock Analysis page.